What are the effects of subcutaneous semaglutide added to high daily doses of insulin in patients with type 2 diabetes? Take this course to learn more!

Upon successful completion of this application-based course, participants should be able to:
1. List the benefits of decreasing the total daily dose of insulin.
2. Describe the patient population who may benefit most from the addition of semaglutide to high total daily dose insulin therapy.
3. Review the strengths, limitations, and results of the semaglutide trial.
4. Discuss the role of semaglutide as treatment in type 2 diabetes mellitus patients with a high total daily dose of insulin.
5. Apply the results of the semaglutide trial to a patient case.

Emily Van Klompenburg, PharmD, BACAP
Assistant Professor
South Dakota State University
College of Pharmacy and Allied Health Professions

Emily Van Klompenburg has no relevant financial relationships with ineligible companies to disclose. 

To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read the article cited below.

Meyer J, Dreischmeier E, Lehmann M, Phelan J. The Effects of Adding Semaglutide to High Daily Dose Insulin Regimens in Patients With Type 2 Diabetes. Ann Pharmacother. 2023;57(3):241-250. doi:10.1177/10600280221107381

*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.

This course is included in our Pharmacist Membership. To get more courses like this sent to you every month, sign-up!

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: May 10, 2023
Planned Expiration Date: May 10, 2026 

Copyright 2023, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

RV1-2.24